Windtree Therapeutics (WINT) has released an update.
Windtree Therapeutics, Inc. has announced the engagement of Ladenburg Thalmann & Co. Inc. to explore strategic alternatives aimed at maximizing stockholder value, as detailed in a press release issued on January 31, 2024.
For further insights into WINT stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
